Source link : https://www.newshealth.biz/health-news/rituximab-cyclophosphamide-compared-in-pediatric-vasculitis/
TOPLINE: Rituximab and cyclophosphamide are equally effective in achieving remission or low disease activity rates in childhood-onset antineutrophil cytoplasmic antibody–associated vasculitis (AAV), and those who received rituximab required a significantly lower steroid dose than those who received cyclophosphamide or a combination therapy. METHODOLOGY: Researchers evaluated the efficacy of rituximab, cyclophosphamide, or a combination of both […]
Author : News Health
Publish date : 2024-11-11 10:44:02
Copyright for syndicated content belongs to the linked Source.